The tweet was deleted by the author.
But we saved everything 🙂.
West Pharmaceutical will participate in CPHI South East Asia from July 8 to 10.
The company invites attendees to visit Booth E26. West expert Michael Lei will present on obtaining an integrated verified prefillable syringe system from a single source on July 9.
WST is trading at $329.71, which is firmly above the MA-20 ($321.99), MA-50 ($304.96), and MA-200 ($271.65). This structure supports a bullish short-, medium-, and long-term trend. The Ichimoku Kijun level at $316.36 sits below the current price, acting as immediate support. Near-term support is found at MA-20 ($321.99), with key support at MA-50 ($304.96). Immediate resistance is higher, first at the previous week's high ($331.68), and key resistance is set by the 52-week high ($336.82).
Momentum signals are notably strong: MACD D1 indicates a strong buy, while the ADX D1 at 23.16 supports a healthy trend but is not extreme. RSI D1 is moderately bullish at 59.43, but Stoch RSI and CCI D1 are closer to neutral, with Stoch RSI signaling no clear overbought condition and CCI mildly supportive. BBP is elevated at 4.24, showing buyers dominate intraday momentum. The Awesome Oscillator is neutral and does not reinforce the prevailing uptrend. WST has risen $1.68 (0.51%) over the past week, opening at $328.03 and now holding the upper part of the weekly range. Weekly volatility stands at 3.03%. This reflects a steady advance and consolidation near the weekly high, confirming bullish momentum with no major divergence among oscillators.
For the coming week, the expected price range is $325.00 to $335.00, keeping well within recent volatility and anchored between the 52-week low ($206.80) and high ($336.82). Based on the alignment of W1 MA-50, RSI, ADX, and MACD (all "Buy"), there is a very high probability (more than 80%) of a further price increase, while the likelihood of a decline is very low. The baseline scenario sees WST oscillating sideways between $325.00 and $335.00. A bullish breakout above $335.00 could open the path to new highs, while a bearish move below $325.00 might spark a short-term pullback toward support at $322.00. The broader backdrop continues to favor buyers, with trend strength confirmed on both daily and weekly horizons.
Previously it was reported that West Pharmaceutical maintained a strong bullish technical profile with the potential for continued upside, provided key supports held. The current article offers a fresh perspective on the prevailing scenario, guiding investors to monitor for any emerging shifts in market momentum that could redefine the near-term trend.